Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

4.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

588
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
588
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.2K
Obesity01:24

Obesity

357
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
357
Coagulation01:09

Coagulation

4.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.0K
Disorders of Hemostasis01:24

Disorders of Hemostasis

676
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
676

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pseudo-Hypertrophy.

International heart journal·2026
Same author

[Overview].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same author

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same author

Phenotypic and Genetic Characteristics of <i>bla</i><sub>IMP-6</sub>-Harboring <i>Enterobacterales</i> Isolates Lacking <i>bla</i><sub>CTX-M-2</sub> in Japan.

International journal of molecular sciences·2026
Same author

Clinical features, pathogenesis, and treatment of anti-MDA5 antibody-positive interstitial lung disease.

Respiratory investigation·2026
Same author

A Functional TNFRSF13B Variant Disrupts B-Cell Enhancer Activity and Increases Susceptibility to EBV-Negative Lymphoma.

Gene·2026

相关实验视频

Updated: May 24, 2025

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

684

组织因子通路驱动的初始血栓生成与肥胖症的高凝血性有关.

Yuichi Kamikubo1, Satomi Nagaya2, Rina Inoue1

  • 1Thrombo Translational Research Lab Inc., Chuo-ku, Kumamoto, Japan.

Thrombosis and haemostasis
|March 6, 2025
PubMed
概括

通过组织因子 (TF) 途径产生初始血栓激素 (TG) 在肥胖症中升高. 这表明含有TF的微囊有助于高凝血,提供了一种新的评估方法.

更多相关视频

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

426
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K

相关实验视频

Last Updated: May 24, 2025

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

684
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

426
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K

科学领域:

  • 生物化学 生物化学
  • 血液学 血液学 血液学
  • 代谢疾病 代谢疾病

背景情况:

  • 组织因子 (TF) 途径启动凝血,并与肥胖相关的高凝血性有关.
  • 现有的测定方法缺乏灵敏度来测量肥胖的初始血栓生成 (TG).
  • TF通路驱动的初始TG与肥胖症中的高凝血性之间的联系需要进一步研究.

研究的目的:

  • 评估TF通路驱动的初始TG与肥胖症中的高凝血性之间的关联.
  • 用一种敏感的测试来评估肥胖小鼠和超重人群的初始TG水平.

主要方法:

  • 从肥胖 (TSOD) 小鼠和超重人类的血中测量初始TG.
  • 通过将TF添加到血和化3分钟来诱导初始TG.
  • 通过使用原基质的氨基溶解活性量化生成FIIa (素).

主要成果:

  • 与非肥胖对照相比,TSOD小鼠的初始TG水平明显较高.
  • 在肥胖小鼠和超重个体中,即使没有外源性TF,在添加前凝类脂后,也观察到初始TG升高.
  • 在来自肥胖小鼠的血颗粒中发现了增加的初始TG,由反TF抗体取消,而不是超,这表明含有TF的微粒.

结论:

  • 在肥胖患者中,TF通路驱动的初始TG显著升高.
  • 增加的促凝剂TF载微囊可能会促进肥胖的初始TG.
  • 测量TF通路驱动的初始TG可以作为评估肥胖症高凝血能力的宝贵生物标志物.